Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03939455 · ClinicalTrials.gov registry record · NA
Mobile Augmented Screening Tool to Increase Adolescent HIV Testing and Linkage to Care
A NA study, sponsored by New York University.
- Completed
- Registry status
- NA
- Development phase
- 295
- Enrollment target
NCT03939455 is a NA study that has completed, run by New York University. The registered enrollment target is 295 participants.
The verdict
NCT03939455, a NA study, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- NA
- Development phase
- 295 participants
- Enrollment target
Study Summary
Because adolescents and young adults face markedly increased HIV risk yet frequently do not test, we propose to complete the Mobile Augmented Screening (MAS) tool designed to increase HIV testing, and to facilitate linkage to care and ongoing prevention education. This tool will help clinicians address undiagnosed youth HIV, and enable young patients to receive much needed treatment and avoid unknowingly transmitting infection. Our product is designed to help existing program staff reach an increased number of clients; and to improve public health by encouraging reluctant young patients to accept important HIV testing and care they may otherwise decline.
Interventions
- OTHER Mobile Augmented Screening tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 295 participants |
| Start Date | 2019-07-22 |
| Est. Completion | 2020-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03939455
The ClinicalTrials.gov registry entry for NCT03939455 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 295 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mobile Augmented Screening tool is the first listed.
NCT03939455 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03939455 about?
NCT03939455 is a clinical study titled "Mobile Augmented Screening Tool to Increase Adolescent HIV Testing and Linkage to Care". Because adolescents and young adults face markedly increased HIV risk yet frequently do not test, we propose to complete the Mobile Augmented Screening (MAS) tool designed to increase HIV testing, and to facilitate linkage to care and ongoing prevention education. This tool will help clinicians addr...
What is the current status of trial NCT03939455?
This trial is currently completed. It is a NA study. The enrollment target is 295 participants. The study started on 2019-07-22. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT03939455?
The interventions under investigation include: Mobile Augmented Screening tool (OTHER).
Who is sponsoring clinical trial NCT03939455?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.